These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection. Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797 [Abstract] [Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pain Pract; 2008 Dec; 8(4):287-313. PubMed ID: 18503626 [Abstract] [Full Text] [Related]
4. [Buprenorphine abuse: high dose intravenous administration of buprenorphine]. Varescon I, Vidal-Trécan G, Nabet N, Boissonnas A. Encephale; 2002 Dec; 28(5 Pt 1):397-402. PubMed ID: 12386540 [Abstract] [Full Text] [Related]
5. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)]. Duburcq A, Charpak Y, Blin P, Madec L. Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303 [Abstract] [Full Text] [Related]
7. Comparison of buprenorphine and methadone effects on opiate self-administration in primates. Mello NK, Bree MP, Mendelson JH. J Pharmacol Exp Ther; 1983 May; 225(2):378-86. PubMed ID: 6188822 [Abstract] [Full Text] [Related]
8. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments]. Lepère B, Gourarier L, Sanchez M, Adda C, Peyret E, Nordmann F, Ben Soussen P, Gisselbrecht M, Lowenstein W. Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989 [Abstract] [Full Text] [Related]
9. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)]. Fhima A, Henrion R, Lowenstein W, Charpak Y. Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992 [Abstract] [Full Text] [Related]
10. Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study. Nava F, Manzato E, Leonardi C, Lucchini A. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1867-72. PubMed ID: 18801404 [Abstract] [Full Text] [Related]
11. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D. Addiction; 2007 Apr 12; 102(4):616-22. PubMed ID: 17286641 [Abstract] [Full Text] [Related]
12. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J, Heilig M, Sarman I. Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989 [Abstract] [Full Text] [Related]
13. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. Negus SS. J Pharmacol Exp Ther; 2006 May 01; 317(2):711-23. PubMed ID: 16456085 [Abstract] [Full Text] [Related]
14. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients? Reed LJ, Glasper A, de Wet CJ, Bearn J, Gossop M. J Clin Psychopharmacol; 2007 Apr 01; 27(2):188-92. PubMed ID: 17414244 [Abstract] [Full Text] [Related]
15. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Binder T, Vavrinková B. Neuro Endocrinol Lett; 2008 Feb 01; 29(1):80-6. PubMed ID: 18283247 [Abstract] [Full Text] [Related]
16. [Substitution therapy in drug addictions]. Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J. Rev Prat; 2003 Jun 15; 53(12):1327-34. PubMed ID: 12920942 [Abstract] [Full Text] [Related]
17. A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance. Caplehorn J, Deeks JJ. Drug Alcohol Rev; 2006 Mar 15; 25(2):157-60. PubMed ID: 16627305 [Abstract] [Full Text] [Related]
18. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation. Ngo HT, Tait RJ, Hulse GK. Arch Gen Psychiatry; 2008 Apr 15; 65(4):457-65. PubMed ID: 18391134 [Abstract] [Full Text] [Related]
19. Buprenorphine use: the international experience. Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Clin Infect Dis; 2006 Dec 15; 43 Suppl 4():S197-215. PubMed ID: 17109307 [Abstract] [Full Text] [Related]
20. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Sacerdote P, Franchi S, Gerra G, Leccese V, Panerai AE, Somaini L. Brain Behav Immun; 2008 May 15; 22(4):606-13. PubMed ID: 18294814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]